| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/24/2002 | US6455286 Psoralens for pathogen inactivation |
| 09/24/2002 | US6455078 Grinding and mixing the plant of diffuse hedyotis, dried rhizome of bistort rhizome, giant knotweed rhizome, dried ripe fruit of chinese magnoliviavine fruit to form mixture, boiling in water, filtering and concentrating the extract |
| 09/24/2002 | US6455063 A ruminant direct fed microbial composition of matter comprising an acidosis inhibiting effective amount of propionibacterum p-63 is provided. a process for reducing acidosis in ruminants or scours in swine by administration of |
| 09/24/2002 | US6455052 A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles gelatine, vegetable hydrocolloids and/or animal protein. |
| 09/24/2002 | US6455048 Immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases. administering a complex of heat shock protein |
| 09/24/2002 | US6455046 Use of mCRP to enhance immune responses |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455038 Administering reovirus for ras-mediated proliferative disorder, tumors |
| 09/24/2002 | US6455037 Transgenic cells express nucleic acid molecules encoding functional recombinant alpha-galactosidase a enzyme |
| 09/24/2002 | CA2213302C Method of preventing or treating alimentary tract damage due to chemotherapy or radiation |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2063273C Surfactant compositions and methods |
| 09/19/2002 | WO2002073188A1 Method for generating replacement cells and/or tissues |
| 09/19/2002 | WO2002073187A1 Method for generating replacement cells and/or tissues |
| 09/19/2002 | WO2002072850A1 Activated dual specificity lymphocytes and their methods of use |
| 09/19/2002 | WO2002072813A1 Monochromatic fluid treatment systems |
| 09/19/2002 | WO2002072799A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | WO2002072798A1 Fas ligand-expressing hematopoietic cells for transplantation |
| 09/19/2002 | WO2002072796A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 09/19/2002 | WO2002072762A2 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072429A1 Albumin in a flexible polymeric container |
| 09/19/2002 | WO2002072144A1 Remedies for nerve damages |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072117A1 Peptide-isolation process and product made thereby |
| 09/19/2002 | WO2002072116A1 Myb-transformed blood cells and their use for active ingredient screening |
| 09/19/2002 | WO2002072113A1 Wound healing using fibroblasts |
| 09/19/2002 | WO2002072110A1 Caloporoside derivatives, methods for the production thereof and their use |
| 09/19/2002 | WO2002072027A2 Oncolytic rna replicons |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002062361A9 Antiviral composition containing propolis and essential oils |
| 09/19/2002 | WO2002055095A3 Use of aziridino-compounds in the treatment of immune dysfunctions |
| 09/19/2002 | WO2002053181A8 Enterohemorragic escherichia coli vaccine |
| 09/19/2002 | WO2002052934A3 Pesticidal and antiparasitic compositions |
| 09/19/2002 | WO2002045569A3 Method for precipitating red blood cells |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |
| 09/19/2002 | WO2001092299A9 Adenovirus particles with mutagenized fiber proteins |
| 09/19/2002 | WO2001083729A3 Vectors for ocular transduction and use thereof for genetic therapy |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | US20020133835 Genetically engineering vertebrate germ cells; obtain gonads, incubate in transfection mixture and nucleotide sequences, transfect, recover transfected germ cells |
| 09/19/2002 | US20020133235 Cell-culture and polymer constructs |
| 09/19/2002 | US20020132346 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | US20020132343 System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation |
| 09/19/2002 | US20020132342 Generating immortalized dendritic cells; obtain cells, culture, maintain culture of dendritic cells, monitor gene expression from cell culture |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020132225 Compositions and methods for prolonging survival of chilled platelets |
| 09/19/2002 | US20020131963 Methods and compositions for treating type i diabetes using glutamic acid decarboxylase |
| 09/19/2002 | US20020131958 Method for purifying a biological composition |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020131891 For processing and collecting blood, blood constituents, or other suspensions of cellular material |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441434A1 Remedies for nerve damages |
| 09/19/2002 | CA2441213A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | CA2439702A1 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof |
| 09/19/2002 | CA2439612A1 Modulation of smooth muscle cell proliferation |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241249A1 CD4+CD25+regulatory T cells from human blood |
| 09/18/2002 | EP1240518A1 Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors |
| 09/18/2002 | EP1240345A2 Methods for expression of genes in primates |
| 09/18/2002 | EP1240344A1 Replication incompetent herpes viruses for use in gene therapy |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240192A2 Attenuated microorganisms for the treatment of infection |
| 09/18/2002 | EP1239897A1 Tissue regenerative composition |
| 09/18/2002 | EP1239895A2 A process for preparing an autologous platelet gel and membranes thereof |
| 09/18/2002 | EP1239875A1 Procedure to use staphylococcal bacteria |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239865A1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 09/18/2002 | EP1239742A1 Honey based food product for relief of stomach and intestine complaints and compressed product comprising said composition |
| 09/18/2002 | EP1225906A4 Mechanically elongated neuronal cells and methods for producing and using these cells |
| 09/18/2002 | EP1185622A4 Methods of making pancreatic islet cells |
| 09/18/2002 | EP0954565A4 Adipogenic differentiation of human mesenchymal stem cells |
| 09/18/2002 | EP0790768A4 In vitro tissue and organ equivalent models |
| 09/18/2002 | EP0759765B1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 09/18/2002 | CN1370240A Regulation system of expression using nuclear PPAR receptors |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1369550A Culture medium of staphylococcus aureus and its preparing process |
| 09/18/2002 | CN1369308A Liniment 'Rubikang' and its preparing process |
| 09/18/2002 | CN1369283A Eye drops containing bio-active catalytic enzyme |
| 09/18/2002 | CN1369280A 'Kangneng Pingheng' oral liquid |
| 09/18/2002 | CN1369277A Exterior-applied plaster for treating lumbar vertebra disease, cervical vertebra disease and osteoarthropathy and its preparing process |
| 09/18/2002 | CN1369271A Bee larve extract and its preparing process |
| 09/18/2002 | CN1369270A Pearl shell capsule and its preparing process |
| 09/18/2002 | CN1369260A Face-beautifying liniment for eliminating sore from face |
| 09/18/2002 | CN1090971C Uropoly acid-peptide compsn. |
| 09/18/2002 | CN1090970C Process for preparing uropoly acid-peptide compsn. |
| 09/18/2002 | CN1090966C Ointment |
| 09/18/2002 | CN1090964C Powered medicine for treating liver cancer, gastric cancer, lung cancer and esophags cancer |
| 09/18/2002 | CN1090963C Fast-acting nemostatic pellet |
| 09/18/2002 | CN1090958C Chinese patent medicine for treating peptide ulcer |
| 09/18/2002 | CN1090956C Tibetan pill for treating cholecytitis and gallstones, and method for preparing same |